Ajanta Pharma Limited (BOM:532331)
India flag India · Delayed Price · Currency is INR
2,607.30
-63.10 (-2.36%)
At close: Feb 21, 2025

Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 325.52 billion. The enterprise value is 318.43 billion.

Market Cap 325.52B
Enterprise Value 318.43B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date Jan 27, 2025
Ex-Dividend Date Nov 6, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.87%
Shares Change (QoQ) -0.12%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 41.84M

Valuation Ratios

The trailing PE ratio is 36.26.

PE Ratio 36.26
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 8.89
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 35.47
EV / Sales 7.03
EV / EBITDA 25.32
EV / EBIT 28.30
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA 0.03
Debt / FCF n/a
Interest Coverage 69.49

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 19.47%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 5.61M
Profits Per Employee 1.11M
Employee Count 8,073
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +23.27% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +23.27%
50-Day Moving Average 2,796.02
200-Day Moving Average 2,800.37
Relative Strength Index (RSI) 44.31
Average Volume (20 Days) 6,549

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 45.32 billion and earned 8.98 billion in profits. Earnings per share was 71.57.

Revenue 45.32B
Gross Profit 34.26B
Operating Income 11.25B
Pretax Income 11.98B
Net Income 8.98B
EBITDA 12.45B
EBIT 11.25B
Earnings Per Share (EPS) 71.57
Full Income Statement

Balance Sheet

The company has 7.42 billion in cash and 327.90 million in debt, giving a net cash position of 7.09 billion.

Cash & Cash Equivalents 7.42B
Total Debt 327.90M
Net Cash 7.09B
Net Cash Per Share n/a
Equity (Book Value) 36.77B
Book Value Per Share 293.33
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 75.59%, with operating and profit margins of 24.83% and 19.81%.

Gross Margin 75.59%
Operating Margin 24.83%
Pretax Margin 26.43%
Profit Margin 19.81%
EBITDA Margin 27.48%
EBIT Margin 24.83%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 54.00, which amounts to a dividend yield of 2.07%.

Dividend Per Share 54.00
Dividend Yield 2.07%
Dividend Growth (YoY) n/a
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield 0.87%
Shareholder Yield 2.94%
Earnings Yield 2.76%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date Jun 22, 2022
Split Type Forward
Split Ratio 1.5

Scores

Altman Z-Score n/a
Piotroski F-Score n/a